Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...

Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...

Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...

Conduit Pharmaceuticals (CDT) announces an agreement with Charles River Laboratories (CRL) to evaluate AZD1656 in a clinically relevant ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

Objectives Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. SLE is a disease ...

The malls of the 2000s are gone with brands like Macy’s, Sears and JCPenney’s that used to serve as the anchor points for ...

An interaction logistic-regression model, in which factors meeting a 0.05 significance level from the main-effect ... and the retrospective nature of these analyses means the results need confirmation ...

Obinutuzumab is a type II anti-CD20 antibody that results in greater B-cell depletion than rituximab; in a preclinical study, obinutuzumab was shown to be more effective than rituximab in a murine ...

Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109, USA Dr J P Lynch III, Department of Internal Medicine, Division of Pulmonary and Critical ...

Harvey Levin, executive producer of TMZ, says Kanye West’s recent behaviors “should be an example of how extreme things need ...